Pharming Group N V Revenue per Employee (PHAR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pharming Group N v   (NASDAQ: PHAR)
 

Pharming Group N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 26.56% in the fourth quarter 2025, year on year to cumulative value of $376 million, Pharming Group N V 's revenue per employee grew on a trailing twelve months basis to $ 1,859,574, this marks a new company high.
Within the Healthcare sector Employees of 40 other companies have achieved higher revenue per employee. While Pharming Group N V 's total ranking has deteriorated compared to the previous quarter from 0 to 554. Pharming Group N V has 202 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PHAR Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 26.56 % - - - 21.09 %
Sales per Employee (TTM) $ 1,859,574 1,469,312 1,469,312 1,469,312 1,469,312
PHAR's Total Ranking # 554 # 0 # # #
Seq. Revenue Change - - - - -

PHAR Company Profile >> Back to PHAR Efficiency Comparisons >> Compare PHAR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 41
Overall Market # 554

Revenue per Employee Statistics
High Average Low
$ 1,859,574 $ 1,262,384 $ 984,510
(Dec 31 2025)   (Dec 31 2021)



Financial Statements
Pharming Group N V 's Revenue MRQ $ 376 Millions Visit PHAR's Income Statement
Pharming Group N V 's Revenues TTM $ 376 Millions Visit PHAR's aggregate revenue growth
What are PHAR's Sales? Visit PHAR's Sales by Segment




Other Ratios
Pharming Group N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PHAR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PHAR's Competitors
Revenue per Employee for PHAR's Suppliers
Revenue per Employee for PHAR's Customers

You may also want to know
PHAR's Sales Growth Rates PHAR's Pe Price to earnings ratio PHAR's Receivables Turnover Ratio PHAR's Stock Quote
PHAR's Net Income Growth Rates PHAR's Ps Price to Sales ratio PHAR's Sales per Employee PHAR's Asset Turnover Ratio
PHAR's Net Margin PHAR's Pb Price to Book ratio PHAR's Financial Strength Ratios PHAR's Dividend Payout Ratio
Date modified: 2026-07-07T12:47:48+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Catalyst Pharmaceuticals Inc   3,236,203.30 $ 588.989  Million 182 
Therapeuticsmd Inc   3,022,000.00 $ 3.022  Million 1 
Harmony Biosciences Holdings inc   2,962,836.18 $ 868.111  Million 293 
Ironwood Pharmaceuticals inc   2,961,510.00 $ 296.151  Million 100 
Amgen Inc   2,827,000.00 $ 36,751.000  Million 13,000 
Spero Therapeutics Inc   2,672,080.00 $ 66.802  Million 25 
Sarepta Therapeutics Inc   2,632,619.16 $ 2,198.237  Million 835 
Grifols Sa  2,622,745.10 $ 8,426.880  Million 3,213 
Innoviva Inc   2,419,289.31 $ 384.667  Million 159 
United Therapeutics Corporation  2,273,357.14 $ 3,182.700  Million 1,400 
Anaptysbio Inc   2,255,798.08 $ 234.603  Million 104 
Assertio Holdings inc   2,239,867.92 $ 118.713  Million 53 
Aurinia Pharmaceuticals Inc   2,211,367.19 $ 283.055  Million 128 
Elite Pharmaceuticals Inc   2,131,496.71 $ 138.547  Million 65 
Exelixis Inc   2,022,777.68 $ 2,320.126  Million 1,147 
Biocryst Pharmaceuticals Inc   2,011,119.54 $ 874.837  Million 435 
Prestige Consumer Healthcare Inc   1,935,594.74 $ 1,103.289  Million 570 
Siga Technologies Inc  1,930,100.04 $ 94.575  Million 49 
Pharming Group N v   1,859,574.26 $ 375.634  Million 202 
Kiniksa Pharmaceuticals International Plc  1,851,267.76 $ 677.564  Million 366 
Collegium Pharmaceutical Inc   1,842,382.98 $ 779.328  Million 423 
Eton Pharmaceuticals Inc   1,812,272.73 $ 79.740  Million 44 
Incyte Corporation  1,807,750.35 $ 5,141.242  Million 2,844 
Ptc Therapeutics inc   1,746,372.35 $ 1,730.655  Million 991 
Zevra Therapeutics Inc   1,745,409.84 $ 106.470  Million 61 
Gilead Sciences Inc   1,731,941.18 $ 29,443.000  Million 17,000 
Privia Health Group Inc   1,731,518.76 $ 2,122.842  Million 1,226 
Rigel Pharmaceuticals Inc  1,691,275.86 $ 294.282  Million 174 
Cormedix Inc   1,590,770.76 $ 303.837  Million 191 
Tg Therapeutics Inc   1,544,578.95 $ 616.287  Million 399 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.